Apolipoprotein E Gene Polymorphisms Are Risk Factors for Spontaneous Intracerebral Hemorrhage: A Systematic Review and Meta-analysis

Abstract

Intracerebral hemorrhage (ICH) is a serious clinical disease with high morbidity, whose pathogenesis might be related to apolipoprotein E (APOE) gene polymorphisms. To comprehensively evaluate the risk factors for ICH occurrence, we performed a meta-analysis. We searched online databases to identify eligible studies based on the relationship between APOE genetic polymorphisms and ICH occurrence risk. Specific and pooled odds ratios (ORs) were calculated and by assessing small study bias, we drew the relationship between APOE polymorphisms and ICH risk. We included 15 eligible studies in our study containing a total of 1642 ICH samples and 5545 normal controls. The comparison of ɛ4 and ɛ3 APOE genotypes revealed that specific and pooled ORs showed a significantly increased odds ratio in ICH patients with the ɛ4 genotype, indicating that ɛ4 gene is a risk factor for ICH occurrence, and the heterogeneity is acceptable. Similarly, it was found that the ɛ2 genotype also contributed to the incidence rate of ICH. However, after the subgroup analysis by ethnicity, this APOE genetic polymorphism acted as a harmful factor only in white populations, but did not show an effect in Asian populations. It was suggested that both ε2 and ε4 APOE alleles were risk factors for ICH in general. They were risk factors in white populations only, neither had a detectable effect in Asian populations after subgroup analysing by ethnicity.

Keywords

intracerebral hemorrhage / apolipoprotein E / allele / genetic polymorphism / meta-analysis

References

[1] BrownRD, WhisnantJP, SicksJD, et al.. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke, 1996, 27(3): 373-380

[2] SturgeonJD, FolsomAR, LongstrethWJ, et al.. Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke, 2007, 38(10): 2718-2725

[3] MahleyRW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science, 1988, 240(4852): 622-630

[4] HattersDM, BudamaguntaMS, VossJC, et al.. Modulation of apolipoprotein E structure by domain interaction: differences in lipid–boud and lipid–free forms. J Biol Chem, 2005, 280(40): 34 288-34 295

[5] OphirG, AmariglioN, Jacob–HirschJ, et al.. Apolipoprotein E4 enhances brain inflammation by modulation of the NF–kappaB signaling cascade. Neurobiol Dis, 2005, 20(3): 709-718

[6] AtadzhanovM, MwabaMH, MukomenaPN, et al.. Association of the APOE, MTHFR and ACE Genes Polymorphisms and Stroke in Zambian Patients. Neurol Int, 2013, 5(4): e20

[7] BoumendjelS, KhodjaD, HamriA, et al.. Apolipoprotein E polymorphism and cerebral stroke. Ann Biol Clin (Paris), 2013, 71(1): 21-26

[8] ChenYC, Lee–ChenGJ, WuYR, et al.. Analyses of interaction effect between apolipoprotein E polymorphism and alcohol use as well as cholesterol concentrations on spontaneous deep intracerebral hemorrhage in the Taiwan population. Clin Chim Acta, 2009, 408(1–2): 128-132

[9] ChowdhuryAH, YokoyamaT, KokuboY, et al.. Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital–based study. J Epidemiol, 2001, 11(3): 131-138

[10] DasS, KaulS, JyothyA, et al.. Association of APOE (E2, E3 and E4) gene variants and lipid levels in ischemic stroke, its subtypes and hemorrhagic stroke in a South Indian population. Neurosci Lett, 2016, 628: 136-141

[11] DuzenliS, PirimI, GepdiremenA, et al.. Apolipoprotein E polymorphism and stroke in a population from eastern Turkey. J Neurogenet, 2004, 18(1): 365-375

[12] GarciaC, PinhoEMT, RochaL, et al.. Cerebral hemorrhage and apoE. J Neurol, 1999, 246(9): 830-834

[13] KokuboY, ChowdhuryAH, DateC, et al.. Agedependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke, 2000, 31(6): 1299-1306

[14] SeifertT, LechnerA, FloohE, et al.. Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population. Cerebrovasc Dis, 2006, 21(4): 266-270

[15] TasdemirN, TamamY, ToprakR, et al.. Association of apolipoprotein E genotype and cerebrovascular disease risk factors in a Turkish population. Int J Neurosci, 2008, 118(8): 1109-1129

[16] WooD, DekaR, FalconeGJ, et al.. Apolipoprotein E, statins, and risk of intracerebral hemorrhage. Stroke, 2013, 44(11): 3013-3017

[17] ZhangR, WangX, LiuJ, et al.. Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage in the Chinese population. Genet Test Mol Biomarkers, 2012, 16(1): 63-66

[18] MccarronMO, HoffmannKL, DelongDM, et al.. Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes. Neurology, 1999, 53(9): 2176-2179

[19] CattoAJ, MccormackLJ, MansfieldMW, et al.. Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand, 2000, 101(6): 399-404

[20] MisraUK, KalitaJ, SomarajanBI. Recurrent intracerebral hemorrhage in patients with hypertension is associated with APOE gene polymorphism: a preliminary study. J Stroke Cerebrovasc Dis, 2013, 22(6): 758-763

[21] CorderEH, SaundersAM, StrittmatterWJ, et al.. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science, 1993, 261(5123): 921-923

[22] CorderEH, SaundersAM, RischNJ, et al.. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet, 1994, 7(2): 180-184

[23] BartzokisG, LuPH, GeschwindDH, et al.. Apolipoprotein E affects both myelin breakdown and cognition: implications for age–related trajectories of decline into dementia. Biol Psychiatry, 2007, 62(12): 1380-1387

[24] KonialisC, SpengosK, IliopoulosP, et al.. The APOE E4 Allele Confers Increased Risk of Ischemic Stroke Among Greek Carriers. Adv Clin Exp Med, 2016, 25(3): 471-478

[25] FalconeGJ, RadmaneshF, BrouwersHB, et al.. APOE epsilon variants increase risk of warfarinrelated intracerebral hemorrhage. Neurology, 2014, 83(13): 1139-1146

[26] LeclercqPD, MurrayLS, SmithC, et al.. Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype. J Neurol Neurosurg Psychiatry, 2005, 76(2): 229-233

[27] GreenbergSM, VonsattelJP, SegalAZ, et al.. Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology, 1998, 50(4): 961-965

[28] TolarM, KellerJN, ChanS, et al.. Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity. J Neurosci, 1999, 19(16): 7100-7110

[29] LynchJR, PinedaJA, MorganD, et al.. Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Ann Neurol, 2002, 51(1): 113-117

[30] DavisSM, BroderickJ, HennericiM, et al.. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology, 2006, 66(8): 1175-1181

[31] LiaquatI, DunnLT, NicollJA, et al.. Effect of apolipoprotein E genotype on hematoma volume after trauma. J Neurosurg, 2002, 96(1): 90-96

[32] BiffiA, AndersonCD, JagiellaJM, et al.. APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol, 2011, 10(8): 702-709

[33] AlbertsMJ, GraffagninoC, McclennyC, et al.. ApoE genotype and survival from intracerebral haemorrhage. Lancet, 1995, 346(8974): 575

[34] RaffeldMR, BiffiA, BatteyTW, et al.. APOE epsilon4 and lipid levels affect risk of recurrent nonlobar intracerebral hemorrhage. Neurology, 2015, 85(4): 349-356